StockData
AIM ImmunoTech Inc. logo

AIM ImmunoTech Inc. (AIM) stock

AIMNYSEBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 2/30
$0.14+0.01 (+3.82%)

Close on Nov 17, 2026Market cap $4.14MP/E –Yield –

AIM ImmunoTech revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

AIM ImmunoTech's revenue for the twelve months ending Jun 30, 2026 was $95.00K, down 21.5% year over year. For fiscal 2025 it was $88.00K, down 48.2% from the year before. Over ten years it grew -4.0% a year on average. The highest annual figure on record is $437.00K in fiscal 2017.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$88.00K-48.2%
FY2024Dec 31, 2024$170.00K-15.8%
FY2023Dec 31, 2023$202.00K+43.3%
FY2022Dec 31, 2022$141.00K+4.4%
FY2021Dec 31, 2021$135.00K-17.2%
FY2020Dec 31, 2020$163.00K+16.4%
FY2019Dec 31, 2019$140.00K-61.9%
FY2018Dec 31, 2018$367.00K-16.0%
FY2017Dec 31, 2017$437.00K+375.0%
FY2016Dec 31, 2016$92.00K-30.8%
FY2015Dec 31, 2015$133.00K-32.5%
FY2014Dec 31, 2014$197.00K+31.3%
FY2013Dec 31, 2013$150.00K-29.6%
FY2012Dec 31, 2012$213.00K+32.3%
FY2011Dec 31, 2011$161.00K+19.3%
FY2010Dec 31, 2010$135.00K+21.6%
FY2009Dec 31, 2009$111.00K–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$26.00K+4.0%
Q1 FY2026Mar 31, 2026$22.00K+37.5%
Q4 FY2025Dec 31, 2025$21.00K-53.3%
Q3 FY2025Sep 30, 2025$26.00K-25.7%
Q2 FY2025Jun 30, 2025$25.00K-50.0%
Q1 FY2025Mar 31, 2025$16.00K-60.0%
Q4 FY2024Dec 31, 2024$45.00K-30.8%
Q3 FY2024Sep 30, 2024$35.00K-23.9%
Q2 FY2024Jun 30, 2024$50.00K-10.7%
Q1 FY2024Mar 31, 2024$40.00K+90.5%
Q4 FY2023Dec 31, 2023$65.00K+116.7%
Q3 FY2023Sep 30, 2023$46.00K+39.4%
Q4 FY2022Dec 31, 2022$56.00K+12.0%
Q3 FY2022Sep 30, 2022$21.00K-36.4%
Q2 FY2022Jun 30, 2022$30.00K+30.4%
Q1 FY2022Mar 31, 2022$33.00K+17.9%
Q4 FY2021Dec 31, 2021$50.00K+19.0%
Q3 FY2021Sep 30, 2021$33.00K-8.3%
Q2 FY2021Jun 30, 2021$23.00K-42.5%
Q1 FY2021Mar 31, 2021$28.00K-37.8%
Q4 FY2020Dec 31, 2020$42.00K-16.0%
Q3 FY2020Sep 30, 2020$36.00K-41.0%
Q2 FY2020Jun 30, 2020$40.00K+37.9%
Q1 FY2020Mar 31, 2020$45.00K-81.3%
Q4 FY2019Dec 31, 2019$50.00K+31.6%
Q3 FY2019Sep 30, 2019$61.00K+84.8%
Q2 FY2019Jun 30, 2019$29.00K-48.2%
Q4 FY2018Dec 31, 2018$240.00K+380.0%
Q3 FY2018Sep 30, 2018$38.00K-57.8%
Q2 FY2018Jun 30, 2018$33.00K-84.5%
Q1 FY2018Mar 31, 2018$56.00K-33.3%
Q4 FY2017Dec 31, 2017$50.00K+212.5%
Q3 FY2017Sep 30, 2017$90.00K+309.1%
Q2 FY2017Jun 30, 2017$213.00K+1320.0%
Q1 FY2017Mar 31, 2017$84.00K–
Q4 FY2016Dec 31, 2016$16.00K–
Q3 FY2016Sep 30, 2016$22.00K–
Q2 FY2016Jun 30, 2016$15.00K–

More AIM ImmunoTech figures

See a number that looks wrong?